| androbio vs Jin | 38–30 | 55.88% |
| androbio vs Kazuya | 29–28 | 50.88% |
| androbio vs King | 21–30 | 41.18% |
| androbio vs Eddy | 12–34 | 26.09% |
| androbio vs Bryan | 21–24 | 46.67% |
| androbio vs Law | 20–23 | 46.51% |
| androbio vs Hwoarang | 18–21 | 46.15% |
| androbio vs Reina | 22–13 | 62.86% |
| androbio vs Paul | 10–14 | 41.67% |
| androbio vs Yoshimitsu | 11–13 | 45.83% |
| androbio vs Feng | 7–14 | 33.33% |
| androbio vs Devil Jin | 8–10 | 44.44% |
| androbio vs Lili | 9–8 | 52.94% |
| androbio vs Jun | 7–10 | 41.18% |
| androbio vs Xiaoyu | 7–9 | 43.75% |
| androbio vs Lars | 7–9 | 43.75% |
| androbio vs Azucena | 7–8 | 46.67% |
| androbio vs Steve | 9–5 | 64.29% |
| androbio vs Jack-8 | 8–6 | 57.14% |
| androbio vs Asuka | 7–6 | 53.85% |
| androbio vs Lee | 10–3 | 76.92% |
| androbio vs Nina | 5–7 | 41.67% |
| androbio vs Dragunov | 5–5 | 50.00% |
| androbio vs Claudio | 1–9 | 10.00% |
| androbio vs Leroy | 4–5 | 44.44% |
| androbio vs Victor | 3–5 | 37.50% |
| androbio vs Panda | 2–5 | 28.57% |
| androbio vs Zafina | 3–3 | 50.00% |
| androbio vs Shaheen | 3–2 | 60.00% |
| androbio vs Leo | 2–2 | 50.00% |
| androbio vs Alisa | 0–4 | 0.00% |
| androbio vs Raven | 2–1 | 66.67% |
| androbio vs Lidia | 1–2 | 33.33% |
| androbio vs Heihachi | 2–1 | 66.67% |
| androbio vs Kuma | 1–0 | 100.00% |
| androbio vs Clive | 1–0 | 100.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.